Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-053452)

Filing Details

Accession Number:: 0001181431-12-053452
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-10-03 17:51:41
Reporting Period:: 2012-10-01

Filing Date:: 2012-10-03
Accepted Time:: 2012-10-03 17:51:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001233	Sangamo Biosciences Inc	SGMO	Biological Products, (No Disgnostic Substances) (2836)	680359556

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1234387	William John Larson	C/O Sangamo Biosciences Inc. Point Richmond Tech Cntr, 501 Canal Blvd Richmond CA 94804		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-10-01	300	$6.15	252,860	No	4	S	Direct
Common Stock	Disposition	2012-10-01	506	$6.16	252,354	No	4	S	Direct
Common Stock	Disposition	2012-10-01	1,869	$6.17	250,485	No	4	S	Direct
Common Stock	Disposition	2012-10-01	1,258	$6.18	249,227	No	4	S	Direct
Common Stock	Disposition	2012-10-01	995	$6.19	248,232	No	4	S	Direct
Common Stock	Disposition	2012-10-01	58	$6.20	248,174	No	4	S	Direct
Common Stock	Disposition	2012-10-01	6,676	$6.21	241,498	No	4	S	Direct
Common Stock	Disposition	2012-10-01	1,940	$6.22	239,558	No	4	S	Direct
Common Stock	Disposition	2012-10-01	1,398	$6.24	238,160	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2012.